Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 10, 1980 - Issue 11
4
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The metabolic fate of tizoprolique acid in baboons

, , , &
Pages 797-803 | Received 18 Mar 1980, Published online: 22 Sep 2008
 

Abstract

1. After oral administration of the anti-lipolytic drug [14C]tizoprolique acid (2-propyl-5-carboxy1[4-14C]thiazole), to baboons (60 mg/kg), the radioactivity was well absorbed and rapidly excreted. During 6 and 24 h respectively, 60±25% (S.D.) and 90±2% were excreted in the urine.

2. Plasmaconcn. of 14C reached a max. (182±65, range 85–221 ±g equiv./ml) at 1–1.5 h after an oral dose, and declined rapidly with an apparent half-life of about 0.5 h. A mean of 77±7% of the 14C in peak plasma samples was bound to plasma proteins, somewhat less than that of [14C]tizoprolique acid (84±5%).

3. Tissue concn. of 14C were highest in an animal killed at 0.5 h after an oral dose, but were lower than those in plasma in all tissues examined except the kidneys.

4. The major metabolite of tizoprolique acid was its glycine conjugate, which accounted for about 80% dose excreted in the 24h urine. About 2% dose was excreted as unchanged drug. About 70% and 20% respectively of plasma 14C were associated with the unchanged drug and its glycine conjugate during the period 15 min to 4h after dosing.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.